Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Drug Safety is Scopus-indexed (Q3, CiteScore 2), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1574-8863Verify ISSN ↗2212-3911Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 184 / 278 | 33rd | Q3 |
| Pharmacology | 240 / 328 | 26th | Q3 |
| Toxicology | 105 / 131 | 20th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q3, CiteScore 2.
Current Drug Safety is Q3 in Pharmacology (medical) (rank 184 of 278), Q3 in Pharmacology (rank 240 of 328) and Q4 in Toxicology (rank 105 of 131), by CiteScore 2025.
Current Drug Safety is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2, which places it in quartile Q3 at the 33rd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.285, quartile Q3, with an H-index of 46.
Current Drug Safety is published by Bentham Science Publishers. Its print ISSN is 1574-8863 and its online ISSN is 2212-3911.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Drug Safety has an h-index of 51 and a 2-year mean of 1.46 citations per paper (OpenAlex). Its Scopus CiteScore is 2, quartile Q3. On 2-year citations it ranks #158 of 271 Scopus journals in Pharmacology (medical).
Current Drug Safety published 60 papers in 2025; its busiest recent year was 2022 with 99. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from India (45.5%), Italy (10.3%) and China (6.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 7 retracted papers are recorded (6.2 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.